Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC).
CAS Number:
[216669-97-5]
Target:
FAP
* VAT and and shipping costs not included. Errors and price changes excepted